• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽类抗生素与其他抗菌药物联合对浮游菌和生物膜细胞中广泛耐药菌的活性

Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant in the Planktonic and Biofilm Cell.

作者信息

Meng Qianlin, Lin Fei, Ling Baodong

机构信息

Sichuan Province College Key Laboratory of Structure-Specific Small Molecule Drugs, Chengdu Medical College, Chengdu, China.

School of Pharmacy, Chengdu Medical College, Chengdu, China.

出版信息

Front Pharmacol. 2022 May 11;13:890955. doi: 10.3389/fphar.2022.890955. eCollection 2022.

DOI:10.3389/fphar.2022.890955
PMID:35645826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9130746/
Abstract

is one of the most dangerous opportunistic pathogens in the global health care setup. Its drug resistance and biofilm-forming capability are often associated with chronic infections that are difficult to treat. Therefore, the clinical treatments for highly drug-resistant are limited. Antimicrobial peptides are broad-spectrum antibacterial agents combined with antibiotics that minimize selective bacterial resistance and enhance antibacterial efficacy. The current study evaluated the synergistic antibacterial activities of clinically important peptide antibiotics combined with other antimicrobials against nine extensively drug-resistant strains in planktonic and biofilm cells . Polymyxin B and E combined with imipenem showed 100% synergy in the planktonic cell with the checkerboard. Moreover, polymyxin E with rifampicin and bacitracin with imipenem or meropenem showed 100% additive effects. In the biofilm cell, polymyxin B and E combined with azithromycin showed 100% synergy, when vancomycin with azithromycin, rifampicin, and bacitracin with azithromycin or rifampicin, and teicoplanin with tigecycline or rifampicin, all showed 100% additive effects. Therefore, peptide antibiotics combined with other antimicrobials have synergistic or additive effects on extensively drug-resistant in planktonic and biofilm cells. In addition, the combination of polymyxins with carbapenems or azithromycin could be an ideal therapy against extensively drug-resistant infections.

摘要

是全球医疗体系中最危险的机会性病原体之一。其耐药性和生物膜形成能力常与难以治疗的慢性感染相关。因此,针对高度耐药菌的临床治疗方法有限。抗菌肽是与抗生素联合使用的广谱抗菌剂,可将细菌的选择性耐药性降至最低并增强抗菌效果。本研究评估了临床上重要的肽类抗生素与其他抗菌剂联合对9株浮游菌和生物膜菌中的广泛耐药菌的协同抗菌活性。多粘菌素B和E与亚胺培南联合在浮游菌中棋盘法显示100%协同作用。此外,多粘菌素E与利福平以及杆菌肽与亚胺培南或美罗培南显示100%相加作用。在生物膜菌中,多粘菌素B和E与阿奇霉素联合显示100%协同作用,而万古霉素与阿奇霉素、利福平,杆菌肽与阿奇霉素或利福平,替考拉宁与替加环素或利福平,均显示100%相加作用。因此,肽类抗生素与其他抗菌剂联合对浮游菌和生物膜菌中的广泛耐药菌具有协同或相加作用。此外,多粘菌素与碳青霉烯类或阿奇霉素联合可能是治疗广泛耐药菌感染的理想疗法。

相似文献

1
Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant in the Planktonic and Biofilm Cell.肽类抗生素与其他抗菌药物联合对浮游菌和生物膜细胞中广泛耐药菌的活性
Front Pharmacol. 2022 May 11;13:890955. doi: 10.3389/fphar.2022.890955. eCollection 2022.
2
In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases.多粘菌素B联合亚胺培南、利福平及阿奇霉素对产OXA-23型碳青霉烯酶的多重耐药鲍曼不动杆菌的体外活性
Ann Clin Microbiol Antimicrob. 2006 Apr 21;5:10. doi: 10.1186/1476-0711-5-10.
3
In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii.生物膜抑制剂联合抗菌药物对广泛耐药鲍曼不动杆菌的体外活性。
Sci Rep. 2020 Oct 22;10(1):18097. doi: 10.1038/s41598-020-75218-y.
4
Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.黏菌素与多黏菌素 B 对泛耐药和广泛耐药鲍曼不动杆菌的协同作用。
Int J Antimicrob Agents. 2019 May;53(5):663-668. doi: 10.1016/j.ijantimicag.2019.03.009. Epub 2019 Mar 14.
5
In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.抗菌药物联合对耐黏菌素鲍曼不动杆菌临床分离株的体外协同活性
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6774-6779. doi: 10.1128/AAC.00839-16. Print 2016 Nov.
6
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
7
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].舒巴坦与亚胺培南、美罗培南和头孢哌酮联合对耐碳青霉烯类鲍曼不动杆菌分离株的体外协同活性
Mikrobiyol Bul. 2014 Apr;48(2):311-5. doi: 10.5578/mb.7104.
8
In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.新加坡碳青霉烯类耐药不动杆菌属各种抗菌药物联合的体外活性。
J Antibiot (Tokyo). 2009 Dec;62(12):675-9. doi: 10.1038/ja.2009.99. Epub 2009 Oct 30.
9
Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii.比较代谢组学揭示了多黏菌素 B 和利福平联合用药对多重耐药鲍曼不动杆菌协同作用相关的关键途径。
Biochem Pharmacol. 2021 Feb;184:114400. doi: 10.1016/j.bcp.2020.114400. Epub 2020 Dec 30.
10
Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.非多黏菌素类联合用药作为治疗碳青霉烯类耐药鲍曼不动杆菌感染的潜在替代品。
Int J Antimicrob Agents. 2020 Oct;56(4):106115. doi: 10.1016/j.ijantimicag.2020.106115. Epub 2020 Jul 25.

引用本文的文献

1
Antimicrobial Peptides: A Promising Alternative to Conventional Antimicrobials for Combating Polymicrobial Biofilms.抗菌肽:对抗多种微生物生物膜的传统抗菌药物的一种有前景的替代物。
Adv Sci (Weinh). 2025 Jan;12(1):e2410893. doi: 10.1002/advs.202410893. Epub 2024 Nov 12.
2
GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant .GATR-3,一种可根除多重耐药菌已形成生物被膜的肽 。
Antibiotics (Basel). 2023 Dec 31;13(1):39. doi: 10.3390/antibiotics13010039.
3
Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR .具有抗多重耐药菌抗菌和抗生物膜活性的计算机设计抗菌肽
Antibiotics (Basel). 2023 Sep 1;12(9):1396. doi: 10.3390/antibiotics12091396.
4
Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro.美罗培南联合黄芩苷对广泛耐药和全耐药鲍曼不动杆菌临床分离株具有协同作用。
Pathog Dis. 2023 Jan 17;81. doi: 10.1093/femspd/ftad007.
5
Drug‑resistant : From molecular mechanisms to potential therapeutics (Review).耐药性:从分子机制到潜在疗法(综述)
Exp Ther Med. 2023 Mar 23;25(5):209. doi: 10.3892/etm.2023.11908. eCollection 2023 May.

本文引用的文献

1
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100,31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.
2
Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations with Plant-Derived Compounds against Biofilms and Their Effects on the Metabolomic Profile of Biofilms.环丙沙星单独及与植物源化合物联合使用时的亚抑菌浓度对生物膜的影响及其对生物膜代谢组学特征的作用
Antibiotics (Basel). 2021 Apr 9;10(4):414. doi: 10.3390/antibiotics10040414.
3
Combination inhibition activity of chlorhexidine and antibiotics on multidrug-resistant Acinetobacter baumannii in vitro.体外研究洗必泰与抗生素联合抑制多重耐药鲍曼不动杆菌的活性。
BMC Infect Dis. 2021 Mar 17;21(1):266. doi: 10.1186/s12879-021-05963-6.
4
Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.两种抗菌肽(乳链菌肽和 P10)与常规抗生素联合对抗广泛耐药鲍曼不动杆菌和耐多粘菌素铜绿假单胞菌的协同作用。
Microb Pathog. 2021 Jan;150:104700. doi: 10.1016/j.micpath.2020.104700. Epub 2020 Dec 17.
5
Biofilm-Induced Antibiotic Resistance in Clinical Isolates.临床分离株中生物膜诱导的抗生素耐药性
Antibiotics (Basel). 2020 Nov 17;9(11):817. doi: 10.3390/antibiotics9110817.
6
In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii.生物膜抑制剂联合抗菌药物对广泛耐药鲍曼不动杆菌的体外活性。
Sci Rep. 2020 Oct 22;10(1):18097. doi: 10.1038/s41598-020-75218-y.
7
Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.扎鲁司特是一种广谱硫醇异构酶抑制剂,能抑制血栓形成而不改变出血时间。
Br J Pharmacol. 2021 Feb;178(3):550-563. doi: 10.1111/bph.15291. Epub 2021 Jan 4.
8
Synergistic Potential of Antimicrobial Combinations Against Methicillin-Resistant .抗甲氧西林耐药菌抗菌组合的协同潜力
Front Microbiol. 2020 Aug 17;11:1919. doi: 10.3389/fmicb.2020.01919. eCollection 2020.
9
Bacteriocin-a potential antimicrobial peptide towards disrupting and preventing biofilm formation in the clinical and environmental locales.细菌素——一种有潜力的抗菌肽,可破坏和预防临床和环境场所的生物膜形成。
Environ Sci Pollut Res Int. 2020 Dec;27(36):44922-44936. doi: 10.1007/s11356-020-10989-5. Epub 2020 Oct 1.
10
Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones.普萘洛尔、氯丙嗪和双氯芬酸恢复了广泛耐药(XDR)鲍曼不动杆菌对氟喹诺酮类药物的敏感性。
PLoS One. 2020 Aug 26;15(8):e0238195. doi: 10.1371/journal.pone.0238195. eCollection 2020.